Chemical Structure (Hydralazine 01)
Hydralazine Tablet
Product Images NDC 75834-126
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydralazine (NDC 75834-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (25 mg Tablet Bottle Label)
Hydralazine Hydrochloride Tablets are a medication used to treat high blood pressure. Each tablet contains 25mg of hydralazine hydrochloride, with a recommended dose detailed on the package. They are manufactured by Nivagen Pharmaceuticals in Sacramento, CA, with an emergency number provided. The medication should be stored in a tightly secured container, away from children. The text consists of package information, dosage advice, and manufacturer details.*
Principal Display Panel (50 mg Tablet Bottle Label)
This is a description of a medication called HydrALAZINE Hydrochloride Tablets USP. Each tablet contains 50 mg hydralazine hydrochloride, USP. The usual dosage information can be found in the package insert. It should be stored at 20° to 25°C and dispensed in a tight, light-resistant container with an acid-resistant closure, as required by the USP. It is important to keep this medication, and all medications, out of the reach of children. The manufacturer is Nivagen Pharmaceuticals and it was manufactured in India by Gadila Pharmaceuticals Ltd. The NDC number for this medication is 75834-127-01.*
Principal Display Panel (100 mg Tablet Bottle Label)
This is a description of HydrALAZINE Hydrochloride Tablets USP, containing 100 tablets with 100mg of hydralazine hydrochloride each. The packaging includes full prescribing information, and the tablets should be stored between 20-25°C in a controlled room temperature. The medication must be kept out of reach of children and dispensed in a container with child-resistant closure as required by the USP. It is manufactured for Nivagen Pharmaceuticals, based in Sacramento, California, and manufactured by Cadila Pharmaceuticals Ltd. in India. The package also includes its Mig.Lic. No. 6/1500 and the Issued date: 08/2016.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
